FDA rejects skin test for blocked arteries
This article was originally published in Clinica
Executive Summary
The US FDA has rejected a 510(k) submission from Canadian company PreMD for its point-of-care skin cholesterol test for atherosclerosis (blocked arteries).
You may also be interested in...
Pipeline Acquisitions, Co-Promotion Deals, To Drive Ipsen
Ipsen’s business strategy calls for accessing external innovation across its pipeline, combined with geographic expansion, realizing the unmet potential of its marketed products and business efficiencies in manufacturing and operations.
Biden COVID-19 Plan Would Grow Domestic Manufacturing Base
The proposal, which would increase capacity for pandemic supplies, is similar to ideas President Trump embraced pre-pandemic.
People On The Move: Appointments At Sanofi, Enzymatica And Bayer
Sanofi has named the head of its new API business; Sweden's Enzymatica has hired talent from J&J and L'Oreal; and Bayer has a new transformation officer.
Need a specific report? 1000+ reports available
Buy Reports